Top Markets
Coin of the day
Arno Therapeutics, Inc. Arno Therapeutics, Inc.

Arno Therapeutics, Inc.

ARNI
Classifica tra le azioni #42094
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a... Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid tumors and hematological malignancies. Additionally, it is in pre-clinical development for potential applications against a range of microbial targets. AR-42, another innovative oral cancer treatment, is involved in a Phase I investigator-initiated clinical study, targeting both hematological malignancies and solid tumors. To support its research and development efforts, Arno Therapeutics has established licensing agreements with Invivis Pharmaceuticals, Inc., the Regents of the University of Minnesota, and the Ohio State University Innovation Foundation. The company also holds a co-development partnership with Leica Biosystems Newcastle Ltd.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$4.94K
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Arno Therapeutics, Inc. (ARNI)

Categoria

Il prezzo ARNI con la capitalizzazione del mercato della B
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
ARNI
$0.0001
Capitalizzazione di mercato di Arno Therapeutics, Inc.(ARNI)
Capitalizzazione di mercato: $4.94K
A partire dal August 2026, Arno Therapeutics, Inc. ha una capitalizzazione di mercato pari a $4.94K. Questo rende Arno Therapeutics, Inc. la 42094th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Arno Therapeutics, Inc. dal 2008 al 2026
ARNI in paragone con la classifica dei più popolari stocks
Il prezzo per ARNI Attivo B Capitalizzazione del mercato a B Risultati
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$109,085 $4.94K
$5.383T +109,085,297,974.98%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$89,633.05 $4.94K
$4.423T +89,633,053,673.82%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$84,303.33 $4.94K
$4.160T +84,303,331,188.39%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$74,231.43 $4.94K
$3.663T +74,231,425,168.49%
Arno Therapeutics, Inc. Arno Therapeutics, Inc.
$58,586.20 $4.94K
$2.891T +58,586,196,362.01%